原创力文档PressRelease
Dupixent®(dupilumab)late-breakingPhase3COPDresults
presentedatATSandsimultaneouslypublishedintheNew
EnglandJournalofMedicine
DupixentisthefirstandonlyinvestigationalbiologicforCOPDthathasdemonstrateda
significantreductioninmode
您可能关注的文档
- FLAGYL 说明书 10% w w cream 用户手册.pdf
- FLAGYL® Cream 10% w w Monograph说明书用户手册.pdf
- FERRLECIT 说明书 Sodium Ferric Gluconate Complex in Sucrose Injection 用户手册.pdf
- Pr Fasturtec 药品说明书 Rasburicase Powder for Injection 说明书.pdf
- Sanofi-Aventis 用户手册 FASTURTEC (Rasburicase for Injection)说明书.pdf
- Fabrazyme® 药品说明书 Fabrazyme® Agalsidase Beta 说明书.pdf
- Sanofi-FABRAZYME Product Monograph Medical Information说明书用户手册.pdf
- ELOCTATE 说明书用户手册.pdf
- sanofi-aventis 药品说明书 ELOCTATE 250, 500, 750, 1000, 1500, 2000, 3000 IU vial 说明书.pdf
- Dupixent® Dupilumab injection 用户手册说明书.pdf
文档评论（0）